Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

CCR7 Receptor Expression in Mono-MAC-1 Cells: Modulation by Liver X Receptor α Activation and Prostaglandin E 2.

Tanné B, Bernier S, Dumais N.

Int J Inflam. 2015;2015:201571. doi: 10.1155/2015/201571.

2.
3.

Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs.

da Cunha J, Maselli LM, Stern AC, Spada C, Bydlowski SP.

World J Virol. 2015 May 12;4(2):56-77. doi: 10.5501/wjv.v4.i2.56. Review.

4.

Liver X receptors contribute to periodontal pathogen-elicited inflammation and oral bone loss.

Huang N, Shaik-Dasthagirisaheb YB, LaValley MP, Gibson FC 3rd.

Mol Oral Microbiol. 2015 Dec;30(6):438-50. doi: 10.1111/omi.12103.

5.

New clues to understanding HIV nonprogressors: low cholesterol blocks HIV trans infection.

Prasad VR, Bukrinsky MI.

MBio. 2014 Jun 10;5(3):e01396-14. doi: 10.1128/mBio.01396-14.

6.

Alterations in cholesterol metabolism restrict HIV-1 trans infection in nonprogressors.

Rappocciolo G, Jais M, Piazza P, Reinhart TA, Berendam SJ, Garcia-Exposito L, Gupta P, Rinaldo CR.

MBio. 2014 Apr 29;5(3):e01031-13. doi: 10.1128/mBio.01031-13.

7.

Development of therapeutic polymeric nanoparticles for the resolution of inflammation.

Gadde S, Even-Or O, Kamaly N, Hasija A, Gagnon PG, Adusumilli KH, Erakovic A, Pal AK, Zhang XQ, Kolishetti N, Shi J, Fisher EA, Farokhzad OC.

Adv Healthc Mater. 2014 Sep;3(9):1448-56. doi: 10.1002/adhm.201300688.

8.

Transcriptional profiling reveals molecular signatures associated with HIV permissiveness in Th1Th17 cells and identifies peroxisome proliferator-activated receptor gamma as an intrinsic negative regulator of viral replication.

Bernier A, Cleret-Buhot A, Zhang Y, Goulet JP, Monteiro P, Gosselin A, DaFonseca S, Wacleche VS, Jenabian MA, Routy JP, Tremblay C, Ancuta P.

Retrovirology. 2013 Dec 21;10:160. doi: 10.1186/1742-4690-10-160.

9.

HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells.

Rinaldo CR.

Scientifica (Cairo). 2013;2013:164203. doi: 10.1155/2013/164203. Review.

10.

Dendritic cells in progression and pathology of HIV infection.

Manches O, Frleta D, Bhardwaj N.

Trends Immunol. 2014 Mar;35(3):114-22. doi: 10.1016/j.it.2013.10.003. Review.

11.

Cellular and viral mechanisms of HIV-1 transmission mediated by dendritic cells.

Coleman CM, Gelais CS, Wu L.

Adv Exp Med Biol. 2013;762:109-30. doi: 10.1007/978-1-4614-4433-6_4. Review.

12.

The effect of human immunodeficiency virus-1 on monocyte-derived dendritic cell maturation and function.

Fairman P, Angel JB.

Clin Exp Immunol. 2012 Oct;170(1):101-13. doi: 10.1111/j.1365-2249.2012.04628.x.

13.

Retinoic acid and liver X receptor agonist synergistically inhibit HIV infection in CD4+ T cells by up-regulating ABCA1-mediated cholesterol efflux.

Jiang H, Badralmaa Y, Yang J, Lempicki R, Hazen A, Natarajan V.

Lipids Health Dis. 2012 Jul 9;11:69. doi: 10.1186/1476-511X-11-69.

14.

Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanisms.

Hanley TM, Viglianti GA.

J Virol. 2011 Oct;85(20):10834-50. doi: 10.1128/JVI.00789-11.

15.

PPARα and PPARγ protect against HIV-1-induced MMP-9 overexpression via caveolae-associated ERK and Akt signaling.

Huang W, András IE, Rha GB, Hennig B, Toborek M.

FASEB J. 2011 Nov;25(11):3979-88. doi: 10.1096/fj.11-188607.

Items per page

Supplemental Content

Support Center